CL - Colgate-Palmolive Company

NYSE - Nasdaq Real Time Price. Currency in USD
+0.20 (+0.28%)
As of 2:19PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close72.54
Bid72.73 x 800
Ask72.75 x 800
Day's Range72.46 - 73.17
52 Week Range57.41 - 76.41
Avg. Volume3,330,779
Market Cap62.411B
Beta (3Y Monthly)0.81
PE Ratio (TTM)27.67
EPS (TTM)2.63
Earnings DateNov 1, 2019
Forward Dividend & Yield1.72 (2.37%)
Ex-Dividend Date2019-07-17
1y Target Est74.10
Trade prices are not sourced from all markets
  • Business Wire

    Colgate-Palmolive Webcasts Presentation at the Barclays 2019 Global Consumer Staples Conference

    Colgate-Palmolive President and CEO, Noel Wallace, will present on Wednesday, September 4, 2019 at 7:30 a.m. ET at the Barclays 2019 Global Consumer Staples Conference.

  • Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
    Simply Wall St.

    Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

  • Stock Investors Pay Soaring Prices for Safe Havens as Risk Jumps

    Stock Investors Pay Soaring Prices for Safe Havens as Risk Jumps

    Save haven stocks are looking expensive as investors rush for cover amid rising fears of a recession.

  • Benzinga

    Michigan's Cannabis Sector Is Emergent, Thanks To Favorable Legislation

    The US cannabis market, in general, has been opening up, especially since Canada legalized marijuana in late 2018. Despite the progress being slow, 11 states already allow the recreational use of marijuana. Medical marijuana is legal in 33 states.

  • These five U.S. stocks are most vulnerable to an activist attack

    These five U.S. stocks are most vulnerable to an activist attack

    Food delivery firm Grubhub, industrial heavyweight 3M and consumer products giant Colgate Palmolive are all prime targets for activist investors.

  • Colgate warns Venezuelans not to buy fake imported toothpaste brands

    Colgate warns Venezuelans not to buy fake imported toothpaste brands

    Colgate-Palmolive Co is warning Venezuelans not buy fake versions of its toothpaste brands, leading local authorities to issue a health warning, as demand for imported products in Venezuela's dysfunctional economy encourages the spread of knock-off goods. Colgate, in a statement on Monday, said it had alerted Venezuelan health authorities to the potential risk of the "commercialization and use of these falsified products," without giving further details. The Venezuelan National Hygiene Institute said it had determined that some toothpastes claiming to be from Colgate did not contain fluoride.


    Weekly CFO Sells Highlight

    Recent sells from company CFOs Continue reading...

  • Here's Why Procter & Gamble is a Hot Investment Pick Now

    Here's Why Procter & Gamble is a Hot Investment Pick Now

    Procter & Gamble (PG) is benefiting from ongoing initiatives to improve productivity. Also, the company is focused on product improvement, packaging and marketing initiatives and cost-saving plans.

  • Church & Dwight Likely to Keep Gaining on Solid Sales Trend

    Church & Dwight Likely to Keep Gaining on Solid Sales Trend

    Church & Dwight's (CHD) sales are gaining from continued category growth and healthy market share gains. The company's consumer international business has long been contributing to the top line.

  • 8 Dividend Aristocrat Stocks to Buy Now No Matter What

    8 Dividend Aristocrat Stocks to Buy Now No Matter What

    With the U.S.-China trade war seemingly getting uglier by the minute, investors are scrambling for defensive stocks to buy now. Of course, in the most extreme example, you can elect to go all into cash. However, history has proven that to be the worst thing to do. Instead, this is a perfect time to consider dividend aristocrats.First, market uncertainty incentivizes stable dividend stocks to buy now. How so? Passive-income generating companies typically perform better than high-flying growth names during bearish phases. For one thing, investors can still collect their payouts even if their portfolio isn't doing too well. Moreover, organizations that have a history of consistent payouts tend to be levered toward secular or otherwise steady industries.And there's no better paragon of stability than dividend aristocrats. For those who are unfamiliar with the term, dividend aristocrats have three main requirements: they must be equities traded in the S&P 500, have 25 years-plus of dividend increases and meet size/liquidity benchmarks.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Cyclical Stocks to Buy (or Sell) Now However, a word of caution. Just because you put dividend aristocrats in your list of stocks to buy now doesn't guarantee a smooth ride. If the markets turn volatile, you can expect virtually all names to incur red ink.But the major selling point is magnitude. With dividend aristocrats, you're limiting your potential losses due to the robustness of the target company. Better yet, the volatility provides a rare discount for these stalwarts of industry.So with that in mind, here are eight stocks to buy now with a long track record of payouts: Stocks to Buy: McDonald's (MCD)Source: Shutterstock Dividend Yield: 2.1%I'm going to start my list of stocks to buy now with a name I was wrong about: McDonald's (NYSE:MCD). One of the reasons why I didn't like MCD stock was that the Golden Arches apparently wasn't winning over millennials. But recently, I started eating out at McDonald's, and I discovered that the real fundamentals don't match the "paper" data.For instance, the McDonald's app is incredibly convenient. You order what you want on your phone and go up to the counter or the drive-thru. Very quickly, their employees deliver your selected items. And let's talk about the drive-thru: it's lightning-quick, even with rows of waiting cars. That's a major plus for MCD stock.Finally, McDonald's is a proud member of the dividend aristocrats. It has increased its payout consistently over a 43-year period. If a downturn were to impact the markets, MCD stock is a name you'll want to own. Colgate-Palmolive (CL)Source: Shutterstock Dividend Yield: 2.4%When you're on the hunt for stable stocks to buy now, you don't want to get too cute. Instead, you'll want to go with a proven name like Colgate-Palmolive (NYSE:CL). The investment thesis for CL stock is straightforward and simple. Even in times of recession, people still need to brush their teeth. Thus, I expect a steady revenue stream no matter what happens in the coming months and years.I do have one caveat about CL stock: this doesn't quite belong on a list of stocks to buy now if you're interpreting "now" literally. However, I'm still putting it high on my list because I think shares will quickly fall to a more attractive price point. Personally, I'm eyeballing the equity's 200-day moving average, which is around $66. * 5 Cheap Stocks to Buy Now That the Fed Cut Rates But even if you were to hit the buy button now, I believe CL stock will give you excellent protection over the coming months. Keep in mind that Colgate-Palmolive has increased their dividends for 55 years. That's an impressive feat, even compared to other dividend aristocrats. Further, it's a status that management won't give up without a fight. Cardinal Health (CAH)Source: Shutterstock Dividend Yield: 4.5%In recent years, the healthcare sector has suffered a black eye from a public relations standpoint. Thus, it's no surprise that many companies in this segment have faltered. However, I'd consider putting Cardinal Health (NYSE:CAH) on your list of stocks to buy now. Unlike other players in this broad category, CAH stock is strongly levered to secular demand.In other words, Cardinal Health has a wide range of professional medical products. They run the gamut from anesthesia-related equipment to laboratory products down to something as mundane as gloves. While medical technology is always improving, some things will always remain the same. For these everyday concerns in the medical field, Cardinal Health has folks covered. Ultimately, that's a great catalyst for CAH stock.Another factor is that the company very much belongs on the list of dividend aristocrats. While the exact number of dividend increases causes some disagreement, CAH is included in the Proshares S&P 500 Dividend Aristocrats ETF (BATS:NOBL). And whatever the case, it has reliably raised dividends for at least the last 14 years. Aflac (AFL)Source: Shutterstock Dividend Yield: 2%Simply put, Aflac (NYSE:AFL) is a great company with an incredibly relevant service. As you no doubt have learned through their quirky commercials, Aflac specializes in supplemental insurance. Essentially, their range of products protect you financially from incidents that "regular" insurance doesn't cover or cover adequately. Plus, their solutions represent an incremental cost for much peace of mind, bolstering the case for AFL stock.And while most millennials probably think they're invincible, many will encounter situations that give them a reality check. Additionally, they may hear horror stories about how coverage gaps financially ruined one of their peers. Whatever the case, Aflac, and by logical deduction, AFL stock, has opportunities to rise through word of mouth. * 10 Generation Z Stocks to Buy Long Finally, Aflac is one of the most stable stocks to buy now among dividend aristocrats. Currently, the dividend payout ratio for AFL stock is only 25%. That gives management considerable cushion to pay their shareholders while still investing richly in their business. Kimberly-Clark (KMB)Source: Shutterstock Dividend Yield: 3%I don't always prepare for recessions. But when I do, I take a long look at Kimberly-Clark (NYSE:KMB). If you're concerned about a prolonged downturn in the U.S. or global economy, you'll also want to consider KMB stock. As with Colgate-Palmolive, the bullish argument here is very simple: even in recessions, people need to use the bathroom.And without getting graphic, people also need to take care of themselves after a lengthy session with the porcelain throne. Kimberly-Clark offers some of the best products for this endeavor, and I speak from personal experience. Moreover, the company has other family-care products. If you think about it, KMB stock is truly a cradle-to-grave investment.One knock on KMB stock, though, is that its payout ratio of 78% is a bit on the high side. But on the other hand, it pays out an attractive 3% yield. Furthermore, Kimberly-Clark has traded among dividend aristocrats for 46 years. That makes its shares one of the stocks to buy now in my book. Chevron (CVX)Source: Shutterstock Dividend Yield: 4%With the U.S. and China trading barbs and sanctions, it's no surprise that oil companies like Chevron (NYSE:CVX) fell. On surface level, CVX stock currently faces two major headwinds. First, global volatility means lower demand overall for energy. Second, the push for clean and renewable energies makes CVX stock appear antiquated, and perhaps soon approaching irrelevancy.Admittedly, the first point is going to be a major distraction for Chevron. However, even in the middle of a recession, people still require transportation. Thus, I don't see demand falling completely off the cliff. On the second point, I believe green energy is more a gimmick than a practical reality. Our infrastructure is simply not ready to accommodate innovations like electric vehicles on a mass scale. * 10 Generation Z Stocks to Buy Long Granted, CVX stock is a risky play among this list of stocks to buy now. That said, the trade war dynamic should drive shares to an attractive discount. At that point, I think Chevron becomes a bargain because the world still needs fossil-fuel-based energy. AT&T (T)Source: Shutterstock Dividend Yield: 6%With AT&T (NYSE:T), we're really getting into the riskier side of the dividend stocks to buy now. I say this for a couple of reasons. One, with a yield of 6%, sustainability becomes a concern. Second, and a perfect segue, the dividend payout ratio for T stock is on-paper astronomical. Therefore, many bears anticipate that AT&T will lose its status as one of the key dividend aristocrats.However, it's important to point out that telecoms usually have extremely large depreciation and amortization costs. That artificially depresses earnings, which makes the high payout ratio somewhat deceptive. Still, I concede the point that T stock is saddled with an unprecedented debt level. Its big-moat, slow-growth narrative is distracting, especially when we may be headed toward a recession.That said, this criticism focuses on the headline print. In reality, AT&T is one of very few companies that have the resources and know-how to roll out the 5G network. And because we're in a tech cold war with international adversaries, I see the government supporting T stock big time. 3M (MMM)Source: Shutterstock Dividend Yield: 3.5%Last on my list of stocks to buy now is applied-sciences firm 3M (NYSE:MMM). After providing largely steady gains over the last several decades, MMM stock is in trouble. Hitting a peak around February of 2018, shares have formed an ugly bearish trend channel. Efforts to time the bottom have badly bruised speculators.Surely, I'm not alone when I say that I dislike the phrase "this time, it's different." It's almost bad karma to use those words when discussing an investment thesis. However, I genuinely believe that with MMM stock, this is a valid descriptor.One of the toughest challenges for MMM stock is that the underlying company didn't have a relevant product. That calculus has changed with their latest "Flex & Seal Shipping Roll." Essentially, this is a customizable shipping package that doesn't require tape or other cumbersome equipment.Looking at the video demonstration of Flex & Seal, I think it's a game-changer for retail. By logical deduction, then, it's a game-changer for MMM stock.As of this writing, Josh Enomoto is long T stock. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Cyclical Stocks to Buy (or Sell) Now * 7 Biotech ETFs That Should Remain Healthy * 7 of the Hottest AI Stocks to Buy Now The post 8 Dividend Aristocrat Stocks to Buy Now No Matter What appeared first on InvestorPlace.


    Colgate-palmolive Co (CL) CFO Henning I Jakobsen Sold $2.5 million of Shares

    CFO of Colgate-palmolive Co (30-Year Financial, Insider Trades) Henning I Jakobsen (insider trades) sold 33,854 shares of CL on 07/31/2019 at an average price of $73.45 a share. Continue reading...

  • Hot Summer Tips to Keep You Looking Cool
    PR Newswire

    Hot Summer Tips to Keep You Looking Cool

    Beauty and Lifestyle Expert Mercedes Sanchez Shares Tips for Sizzling Summer Style NEW YORK , Aug. 2, 2019 /PRNewswire/ -- With the summer in full swing, summer beauty routines can be tricky as we navigate ...

  • Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock

    Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock

    Clorox (CLX) reports mixed fourth-quarter fiscal 2019 results. Lower taxes and gross margin expansion aid its earnings while lower volume and unfavorable currency hurt sales.

  • Charts Say No Soap to Buying Colgate-Palmolive Just Yet

    Charts Say No Soap to Buying Colgate-Palmolive Just Yet

    It would be best to see if shares of the consumer products giant can hold a key support level before pulling the trigger to buy them.


    Wall Street Red on Wednesday as Fed Cuts Rates

    Advanced Micro Devices declines on 2nd-quarter results Continue reading...

  • Thomson Reuters StreetEvents

    Edited Transcript of CL earnings conference call or presentation 26-Jul-19 3:00pm GMT

    Q2 2019 Colgate-Palmolive Co Earnings Call

  • Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat

    Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat

    Procter & Gamble (PG) posts robust fourth-quarter fiscal 2019 results. Also, the company provided upbeat guidance for fiscal 2020.

  • Dow Jones Edges Higher on Monday

    Dow Jones Edges Higher on Monday

    Anadarko Petroleum reports better-than-expected results Continue reading...

  • Colgate-Palmolive’s Q2 EPS Met Estimates
    Market Realist

    Colgate-Palmolive’s Q2 EPS Met Estimates

    Colgate-Palmolive reported its second-quarter results. Colgate-Palmolive's EPS came in line with the consensus estimate. However, sales fell short. Higher overhead and advertising costs affected operating margins and dragged earnings down.

  • Colgate-Palmolive Co (CL) Q2 2019 Earnings Call Transcript
    Motley Fool

    Colgate-Palmolive Co (CL) Q2 2019 Earnings Call Transcript

    CL earnings call for the period ending June 30, 2019.

  • Colgate (CL) Q2 Earnings & Sales Miss Estimates, Decline Y/Y

    Colgate (CL) Q2 Earnings & Sales Miss Estimates, Decline Y/Y

    Colgate (CL) posts lower-than-expected second-quarter 2019 results. Foreign currency translations remain a major headwind in the quarter.


    Colgate-Palmolive Sales Grow as Consumers Brush Off Higher Prices

    Colgate-Palmolive beat sales forecasts in the second quarter and narrowly missed revenue expectations.

  • Does This Valuation Of Colgate-Palmolive Company (NYSE:CL) Imply Investors Are Overpaying?
    Simply Wall St.

    Does This Valuation Of Colgate-Palmolive Company (NYSE:CL) Imply Investors Are Overpaying?

    Does the July share price for Colgate-Palmolive Company (NYSE:CL) reflect what it's really worth? Today, we will...

  • Colgate-Palmolive (CL) Lags Q2 Earnings and Revenue Estimates

    Colgate-Palmolive (CL) Lags Q2 Earnings and Revenue Estimates

    Colgate-Palmolive (CL) delivered earnings and revenue surprises of -1.37% and -0.02%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • MarketWatch

    Colgate-Palmolive reports earnings in line with expectations, revenue just misses

    Colgate-Palmolive Co. reported second-quarter of $586 million, or 68 cents per share, down from $637 million, or 73 cents per share, in 2018. Adjusted EPS was 72 cents, in line with the FactSet consensus. Revenue of $3.87 billion is roughly unchanged from last year and just below the $3.88 billion FactSet guidance. Colgate-Palmolive recently acquired the Filorga skin care business, which is not included in the guidance, according to a statement from Chief Executive Officer Noel Wallace. Colgate-Palmolive expects full-year sales to be flat to up low-single digits. EPS is expected to decline in the mid-single digits. Colgate-Palmolive shares slipped 0.5% in Friday premarket trading, but are up nearly 21% for the year to date. The S&P 500 index is up nearly 20% for 2019 so far.